Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | 0.00% | +33.33% | -20.00% |
Feb. 15 | Lobe Sciences Ltd. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Lobe Sciences Provides Update on L-130 Clinical Program | MT |
Sales 2022 | - | Sales 2023 | 841K 614K | Capitalization | 3.88M 2.84M |
---|---|---|---|---|---|
Net income 2022 | -12M -8.77M | Net income 2023 | -4M -2.92M | EV / Sales 2022 | - |
Net cash position 2022 | 933K 682K | Net Debt 2023 | 112K 81.86K | EV / Sales 2023 | 4.75 x |
P/E ratio 2022 |
-0.29
x | P/E ratio 2023 |
-0.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.6% |
1 week | +33.33% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Philip Young
CEO | Chief Executive Officer | 66 | 21-01-14 |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 23-09-17 |
Maghsoud Dariani
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Young
CEO | Chief Executive Officer | 66 | 21-01-14 |
Baxter Phillips
COO | Chief Operating Officer | 48 | 22-10-02 |
Michael Petter
BRD | Director/Board Member | - | 21-01-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.02 | 0.00% | 27,000 |
24-04-23 | 0.02 | +33.33% | 5,000 |
24-04-19 | 0.015 | -25.00% | 96,383 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 10:42 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 2.41M | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- LOBE Stock